EP0060445B1 - Process for the resolution of racemates and lactone esters used in said process - Google Patents

Process for the resolution of racemates and lactone esters used in said process Download PDF

Info

Publication number
EP0060445B1
EP0060445B1 EP82101654A EP82101654A EP0060445B1 EP 0060445 B1 EP0060445 B1 EP 0060445B1 EP 82101654 A EP82101654 A EP 82101654A EP 82101654 A EP82101654 A EP 82101654A EP 0060445 B1 EP0060445 B1 EP 0060445B1
Authority
EP
European Patent Office
Prior art keywords
lactone
ester
acid
carboxylic acid
isopropylidene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
EP82101654A
Other languages
German (de)
French (fr)
Other versions
EP0060445A1 (en
Inventor
Colin Dr. Duke
Robert John Dr. Wells
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of EP0060445A1 publication Critical patent/EP0060445A1/en
Application granted granted Critical
Publication of EP0060445B1 publication Critical patent/EP0060445B1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/487Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification

Definitions

  • the present invention relates to a process for the resolution of racemic carboxylic acids into their optically active enantiomers.
  • racemic carboxylic acids are necessary where the properties of the individual optically active enantiomers are to be investigated. This is of particular value where the racemic acids show some biological activity, e.g. pharmaceutical or insecticidal activity, since the biological activity may vary greatly as between the individual optically active enantiomers.
  • a process for the resolution of racemic carboxylic acids into their optically active enantiomers involving esterification with an optically active compound which is characterized in that an optically active enantiomer of 2,3-isopropylidene-ribonic acid-1,4-lactone; 1,2-isopropylidene- glucofuranurone-3,6-lactone; 2-hydroxy-3,3-dimethyl-1,4-butyrolactone or 3,4-isopropylidene-arabino-1,5-lactone is used as the resolving agent.
  • Preferred resolving agents are D(-)-2-hydroxy-3,3-dimethyl-1,4-butyrolactone; 1,2-isopropylidene-(+)-a-D-glucofuranurono-3,6- lactone; 2,3-isopropylidene-D(+)-ribonic acid-1,4-lactone and 3,4-isopropylidene-L-arabino-1,5-lactone.
  • the resolution method according to the present invention involves forming an ester of the racemic carboxylic acid with the lactone to yield a mixture of diastereoisomers. This mixture of diastereoisomers is then separated by physical means into the two optically active diastereoisomers. Following this, the optically active enantiomeric acid may be regenerated from the ester formed.
  • the ester may be formed by any convenient method.
  • One suitable method involves formation of the acid chloride of the racemic carboxylic and followed by reaction of the lactone resolving agent with the acid chloride. This reaction is conveniently carried out in an inert aprotic solvent such as tetrahydrofuran and in the presence of a base such as pyridine.
  • Separation of the resulting mixture of diastereoisomers into the pure optically active diastereoisomers may be effected by any convenient means. It has been found that using the four lactone resolving agents of the present invention resolution of the mixture of diastereoisomeric esters into the individual optically active diastereoisomers can be readily achieved, e.g. by using crystallization or chromatography. Crystallization is the preferred method in view of its comparative simplicity. In the process of the present invention a solvent comprising ethyl acetate and hexane was successfully used in several instances but other solvents or solvent systems may also be employed. The chromatography method used may conveniently be high-performance liquid chromatography carried out on silica gel. The preferred eluant for the chromatography is an ethyl acetate/hexane solvent system preferably containing the solvents in the ratio of 1 :3 or 1 :4.
  • the ester may be hydrolysed to the acid. This may be accomplished by any convenient hydrolysis method, e.g. using base-catalysed hydrolysis. Care must be taken that the hydrolysis conditions are not so vigorous as to cause the optically active enantiomeric acid to revert to a racemic mixture. In many cases the hydrolysis may be carried out using aqueous hydrochloric acid or aqueous sodium hydroxide solution.
  • the resolving agents of the instant invention are known compounds.
  • D(-)- and L(+)-2-hydroxy-3,3-dimethyl-1,4-butyrolactones are also known under the names D(-) and L(+) pantolac- tone and are readily available articles of commerce.
  • 1,2-isopropylidene-(+)- ⁇ -D-glucofuranuron0-3,6-lactone and the corrsponding L(-) compound may be prepared according to the method off "J. Chem. Soc.”, 339 (1941).
  • the corresponding L(-) compound may also be prepared from L-glucose.
  • Chem.”, 1958, 36, 1720 and the corresponding L(-) ribonic acid lactone is readily prepared from L-arabinose by conversion to potassium L-arabonate as described in "Biochem. J.”, 1965, 94, 75 and subsequent reaction with 2,2-dimethoxypropane.
  • 3,4-isopropylidene-L-arabino-1,5-lactone may be prepared from potassium L-arabonate via L-arabonic acid.
  • the corresponding D compound may also be prepared by conventional methods, e.g. using the same method of preparation as for the L form and selective recrystallization.
  • the process of the present invention is applicable generally to racemic carboxylic acids which are capable of forming lactone ester derivatives.
  • carboxylic acids include amino acids, mercapto carboxylic acids, cycloalkyl acids, aralkyl acids and heterocyclic acids wherein the heteroatom is nitrogen, oxygen or sulfur.
  • the process of the invention may for example be employed to resolve acids of insecticidal esters such as those disclosed in German Patent Specification No. 2653189.
  • Such acids are cyclopropane compounds of the general formula: in which R 1 represents hydrogen or a C 1 -C 9 alkoxy group, a C 1 -C 9 alkylthio group, fluoro, chloro, bromo, a C 1 -C 9 alkyl group, a nitro or amino group, R 2 represents hydrogen or a C 1 -C 9 alkyl group or R 1 and R 2 together represent a methylenedioxy group, and R 4 and R 5 are the same or different and represent fluoro, bromo, chloro or a C 1 -C 9 alkyl group.
  • the C 1 -C 9 alkyl group means branched or unbranched alkyl groups such as methyl, ethyl, propyl, butyl, pentyl, heptyl and the like.
  • C 1 -C 9 alkoxy group means groups in which alkyl is as previously defined.
  • the process of the invention may further be employed in the resolution of pharmaceutically active racemic carboxylic acids such as the acidic dibenzofuran derivatives, dibenzothiophene derivatives and carbazoles of the respective formulae I of U.K. Patent Specifications Nos. 1385620, 1471847 and 1572358.
  • Such pharmaceutically active racemic carboxylic acids include those specifically listed in the three patent specifications mentioned above and in particular 6-chloro-a-methyl-carbazole-2-acetic acid and 8-chloro-a-methyl-3-dibenzofuran acetic acid.
  • lactone esters formed by reaction between the four lactones used as resolving agents according to the present invention and optically active carboxylic acids are novel compounds and constitute a further important aspect of the present invention.
  • Preferred esters according to the present invention are those formed by reaction between the four lactone resolving agents employed according to the present invention and the specific carboxylic acids hereinbefore referred to, in particular those possessing pharmaceutical properties or being useful for the preparation of corresponding insecticidal esters.
  • the mixed diastereoisomeric esters of racemic 1 -(4-bromophenyl)-2,2,3,3-tetraftuorocyclo- butane carboxylic acid and 2,3-isopropylidene-D(+)-ribonic acid-1,4-lactone were prepared from the racemic acid (1.15 g) and the lactone using the general method of Example 1 (a) to yield 1.48 g of ester which was recrystallized from ethyl acetate-hexane to give 0.6 g of the R(-)-ester which, on a second recrystallization from ethyl acetate-hexane, gave colourless needles (0.52 g).
  • 1-(4-Ethoxyphenyl)-2,2-dichlorocyclopro- pane carboxylic acid (1 g) was esterified to its mixed diastereoisomers by conversion to the acid chloride and reaction with 2,3-isopropylidene-D(+)-ribonic acid-1,4-lactone (0.71 g) according to the general method of Example 1 (a) to yield 1.53 g of esters.
  • the mixture of diastereoisomeric lactone esters was chromatographed on silica gel using ethyl acetate-hexane (1 :3) to give 0.18 g of the less polar diastereoisomeric lactone ester, 0.97 g of a mixture of the two diastereoisomeric lactone esters and 0.015 g of the more polar diastereoisomeric lactone ester.
  • the lactone esters were hydrolysed using the general method of Example 1 (c) to give pure R(-)- and S(+)-2-chloropropionic acids.
  • Cis-2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropane carboxylic acid (0.8 g) (containing 5% of the corresponding trans-acid as an impurity) was converted to a crude mixture of diastereoisomers using the general method of Example 15.
  • the mixture (1.19 g) was dissolved in hexane and on standing at room temperature gave colourless needles (0.25 g) of the lactone ester of R(+)-cis-2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropane carboxylic acid containing 17% of the R(+)-trans-ester as an impurity.
  • Cis/trans-2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropane carboxylic acid (3.3 g) (cis/trans 2:3) was converted to a crude mixture of diastereoisomers (5.0 g) (cis/trans 1:2 by 1 H N M R) using the general method of Example 15.
  • the mixture (5 g) was dissolved in diisopropyl ether, filtered through celite and the filtrate concentrated to 25 ml and 25 ml of hexane added. Cooling to 0° gave pale-brown mica-like plates (1.4 g) consisting of the R(+)-trans-ester 80% and the R(+)-cis-ester 20%.
  • 1,4,5,6,7,7-Hexachloro-8,9,10-trinorborn-5- ene-2-carboxylic acid may be prepared as follows:
  • the methyl ester (180 g) was dissolved in methanol (625 ml) and 10% aqueous sodium hydroxide (530 ml) was added and the mixture was stirred overnight at room temperature to give a brown solution. Most of the methanol was removed by evaporation under reduced pressure and the aqueous residue was acidified with 2M HCI and extracted with CH 2 Cl 2 ; evaporation of the CH 2 Cl 2 gave a crystalline residue of 1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-ene-2-carboxylic acid which was recrystallized from hexane as colourless crystals (67 g), m.p. 156-70° decomp.
  • 1,4,5,6,7,7-Hexachloro-8,9,10-trinorborn-5- ene-2-carboxylic acid (10 g) was heated with thionyl chloride (10 ml) at 100° for 1.5 h and the excess thionyl chloride removed in vacuo. To the residual liquid was added a tetrahydrofuran (50 ml) solution of L(+)-pantolactone and pyridine (3.5 ml) added slowly to the solution to be stirred. After 3 h the crystalline solid that had formed was filtered and washed with tetrahydrofuran and the filtrate concentrated under reduced pressure.
  • Racemic 1-(4-ethoxyphenyl)-2,2-dichloro- cyclopropane carboxylic acid (10.0 g) and thionyl chloride (5 ml) were heated at 100° under reflux for 2 h and the excess thionyl chloride removed in vacuo. To the residue was added a solution of L(+)-2-hydroxy-3,3-dimethyl-1,4-butyrolactone (5 g) in drytetrahydrofuran (20 ml) followed by pyridine (4 ml). The mixture was allowed to stand at room temperature for 2 h then was partitioned between benzene (100 ml), and 1 M aqueous hydrochloric acid saturated with sodium chloride (100 ml).
  • Racemic 2-(4-chlorophenoxy)-3-methylbutanoic acid (1.0 g) and thionyl chloride (1 ml) were heated under reflux at 100° for 2 h and excess thionyl chloride removed in vacuo.
  • the residue was dissolved in dry tetrahydrofuran (5 ml), L(+)-2-hydroxy-3,3-dimethyl-1,4-butyrolactone (0.65 g) was added and the solution cooled in ice during the addition of pyridine (0.5 ml). The mixture was allowed to stand at room temperature for 2 h.
  • Potassium L-arabonate (11.4 g) (prepared by the method of P. Andrews, L. Hough and J.M. Picken, "Biochem. J.”, 1965, 94, 75) was dissolved in a mixture of water (50 ml) and pyridine (5 ml) and heated at 135° for 3 h in an autoclave. The reaction mixture was evaporated under reduced pressure to remove most of the pyridine and then passed through an ion-exchange column (H + form).
  • Potassium L-arabonate prepared by the method of P. Andrews, L. Hough and J.M. Picken, "Biochem. J.”, 1965, 94, 75
  • the acidic eluant was collected and concentrated to a colourless syrup of L-arabonic acid (14.75 g).
  • the syrup was dissolved in acetone (300 ml) and sulphuric acid (0.5 ml) and cupric sulphate (31 g) was added and the mixture stirred at room temperature for 24 h.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

  • The present invention relates to a process for the resolution of racemic carboxylic acids into their optically active enantiomers.
  • The resolution of racemic carboxylic acids is necessary where the properties of the individual optically active enantiomers are to be investigated. This is of particular value where the racemic acids show some biological activity, e.g. pharmaceutical or insecticidal activity, since the biological activity may vary greatly as between the individual optically active enantiomers.
  • It has previously been proposed to resolve racemic carboxylic acis using suitable optically active amines (forming salts or amides) or chiral alcohols (forming esters) as the resolving agents. The use of amines suffers from the disadvantage that the conditions required for hydrolysis of the amide bond can cause partial or complete race- misation. Furthermore, few chiral alcohols have been reported which form esters which are readily resolved, e.g. by crystallization or chromatography. Among chiral alcohols known as resolving agents for carboxylic acids are (-) menthol, (+) borneol, and (+) or (-) octan-2-ol.
  • It has now been found that four specific lactones readily form esters with racemic carboxylic acids whereby the said lactone esters are readily susceptible to separation into their enantiomers. The enantiomeric acids are obtainable in good yield and a high state of purity using the resolving agents of the instant invention. According to the present invention, therefore there is provided a process for the resolution of racemic carboxylic acids into their optically active enantiomers involving esterification with an optically active compound, which is characterized in that an optically active enantiomer of 2,3-isopropylidene-ribonic acid-1,4-lactone; 1,2-isopropylidene- glucofuranurone-3,6-lactone; 2-hydroxy-3,3-dimethyl-1,4-butyrolactone or 3,4-isopropylidene-arabino-1,5-lactone is used as the resolving agent.
  • Preferred resolving agents are D(-)-2-hydroxy-3,3-dimethyl-1,4-butyrolactone; 1,2-isopropylidene-(+)-a-D-glucofuranurono-3,6- lactone; 2,3-isopropylidene-D(+)-ribonic acid-1,4-lactone and 3,4-isopropylidene-L-arabino-1,5-lactone.
  • The resolution method according to the present invention involves forming an ester of the racemic carboxylic acid with the lactone to yield a mixture of diastereoisomers. This mixture of diastereoisomers is then separated by physical means into the two optically active diastereoisomers. Following this, the optically active enantiomeric acid may be regenerated from the ester formed.
  • The ester may be formed by any convenient method. One suitable method involves formation of the acid chloride of the racemic carboxylic and followed by reaction of the lactone resolving agent with the acid chloride. This reaction is conveniently carried out in an inert aprotic solvent such as tetrahydrofuran and in the presence of a base such as pyridine.
  • Separation of the resulting mixture of diastereoisomers into the pure optically active diastereoisomers may be effected by any convenient means. It has been found that using the four lactone resolving agents of the present invention resolution of the mixture of diastereoisomeric esters into the individual optically active diastereoisomers can be readily achieved, e.g. by using crystallization or chromatography. Crystallization is the preferred method in view of its comparative simplicity. In the process of the present invention a solvent comprising ethyl acetate and hexane was successfully used in several instances but other solvents or solvent systems may also be employed. The chromatography method used may conveniently be high-performance liquid chromatography carried out on silica gel. The preferred eluant for the chromatography is an ethyl acetate/hexane solvent system preferably containing the solvents in the ratio of 1 :3 or 1 :4.
  • Subsequent to the separation of the mixture of diastereoisomeric lactone esters into the optically active enantiomers thereof, the ester may be hydrolysed to the acid. This may be accomplished by any convenient hydrolysis method, e.g. using base-catalysed hydrolysis. Care must be taken that the hydrolysis conditions are not so vigorous as to cause the optically active enantiomeric acid to revert to a racemic mixture. In many cases the hydrolysis may be carried out using aqueous hydrochloric acid or aqueous sodium hydroxide solution.
  • The resolving agents of the instant invention are known compounds. D(-)- and L(+)-2-hydroxy-3,3-dimethyl-1,4-butyrolactones are also known under the names D(-) and L(+) pantolac- tone and are readily available articles of commerce. 1,2-isopropylidene-(+)-α-D-glucofuranuron0-3,6-lactone and the corrsponding L(-) compound may be prepared according to the method off "J. Chem. Soc.", 339 (1941). The corresponding L(-) compound may also be prepared from L-glucose. According to an alternative method of preparation oxidation of D-glucose with air in the presence of either platinum (Heyns and R. Heine- mann, "Ann.", 1947, 558, 187) or palladium (M. Busch, "G.P.", 702, 729/1941) gave D-glucuronic acid, evaporation of an aqueous solution of D-glucuronic acid yields crystalline D-glucofuranurono-6,3-lactone (F. Smith, "J. Chem. Soc.", 1944,584; A Baeyer, "Ann.", 1870, 155, 257). 2,3-)sopropytidene-D(+)-ribonic acid-1,4-tactone may be prepared from D(+)-ribonic acid-1,4-tactone according to the method of "Can. J. Chem.", 1958, 36, 1720 and the corresponding L(-) ribonic acid lactone is readily prepared from L-arabinose by conversion to potassium L-arabonate as described in "Biochem. J.", 1965, 94, 75 and subsequent reaction with 2,2-dimethoxypropane. 3,4-isopropylidene-L-arabino-1,5-lactone may be prepared from potassium L-arabonate via L-arabonic acid. The corresponding D compound may also be prepared by conventional methods, e.g. using the same method of preparation as for the L form and selective recrystallization.
  • The process of the present invention is applicable generally to racemic carboxylic acids which are capable of forming lactone ester derivatives. Examples of such carboxylic acids include amino acids, mercapto carboxylic acids, cycloalkyl acids, aralkyl acids and heterocyclic acids wherein the heteroatom is nitrogen, oxygen or sulfur. The process of the invention may for example be employed to resolve acids of insecticidal esters such as those disclosed in German Patent Specification No. 2653189.
  • Such acids are cyclopropane compounds of the general formula:
    Figure imgb0001
    in which R1 represents hydrogen or a C1-C9 alkoxy group, a C1-C9 alkylthio group, fluoro, chloro, bromo, a C1-C9 alkyl group, a nitro or amino group, R2 represents hydrogen or a C1-C9 alkyl group or R1 and R2 together represent a methylenedioxy group, and R4 and R5 are the same or different and represent fluoro, bromo, chloro or a C1-C9 alkyl group. The C1-C9 alkyl group means branched or unbranched alkyl groups such as methyl, ethyl, propyl, butyl, pentyl, heptyl and the like. C1-C9 alkoxy group means groups in which alkyl is as previously defined.
  • Specific examples of insecticidal acids which normally exist as racemic mixtures and which may conveniently be resolved into their enantiomers by the process of the present invention include:
    • Cis-3-(2,2-dichlorovinyl)-2,2-dimethyl-cyclopropane carboxylic acid;
    • Cis/trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid;
    • Cis-3-(2,2-dibromovinyl)-2,2-dimethyl-cyclopropane carboxylic acid;
    • 3-(1,2-Dibromo-2,2-dichloroethyl)-2,2-dimethyl-cyclopropane carboxylic acid;
    • 2,2-Dimethyl-3-(2,2,2-trichloroethyl)-cyclopropane carboxylic acid;
    • 2,2-Dimethyl-4,5-benzospiro-[2,4]-hepta-4,6-diene-1 -carboxylic and;
    • Cis-3-(Z-2-chloro-3,3,3-trifluoroprop-1 - enyl) -2,2-dimethyl-cyclopropane carboxylic acid;
    • 2-(2-Chloro-a,a,a-trifluoro-p-toluidino)-3-methyl lactic acid;
    • 2-(4-Chlorophenyl)-3-methyl lactic acid;
    • 2-(4-Chlorophenoxy)-3-methylbutanoic acid;
    • 2-(4-Difluoromethoxyphenyl)-3-methyl lactic acid;
    • 1 - (4- Ethoxyphenyl) -2,2,3,3-tetraftuorocyclo- butane carboxylic acid;
    • 1-(4-Bromophenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid;
    • 1 - (4- Ethoxyphenyl) -2,2-dichlorocyclopro- pane carboxylic acid;
    • 1-(4-Chlorophenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid;
    • 1-(3,4-Methylenedioxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid;
    • 2,2-Dimethyl-3-(2,2-dichlorovinyl)-cyclopropane carboxylic acid; and
    • 1,4,5,6,7,7-Hexachloro-8,9,10-trinorborn-5- ene-2-carboxylic acid.
  • The process of the invention may further be employed in the resolution of pharmaceutically active racemic carboxylic acids such as the acidic dibenzofuran derivatives, dibenzothiophene derivatives and carbazoles of the respective formulae I of U.K. Patent Specifications Nos. 1385620, 1471847 and 1572358.
  • Specific examples of such pharmaceutically active racemic carboxylic acids include those specifically listed in the three patent specifications mentioned above and in particular 6-chloro-a-methyl-carbazole-2-acetic acid and 8-chloro-a-methyl-3-dibenzofuran acetic acid.
  • The lactone esters formed by reaction between the four lactones used as resolving agents according to the present invention and optically active carboxylic acids are novel compounds and constitute a further important aspect of the present invention.
  • Also according to the present invention, therefore there are provided diastereoisomeric esters of an optically active enantiomer of 2,3-isopropylidene-ribonic acid-1,4-lactone, 1,2-isopropylidene-glucofuranurono-3,6-lactone, 2-hydroxy-3,3-dimethyl-1,4-butyrolactone or 3,4-isopropylidene-arabino-1,5-lactone and an optically active carboxylic acid, said acid being either in racemic form or as single optically active enantiomer thereof.
  • Preferred esters according to the present invention are those formed by reaction between the four lactone resolving agents employed according to the present invention and the specific carboxylic acids hereinbefore referred to, in particular those possessing pharmaceutical properties or being useful for the preparation of corresponding insecticidal esters.
  • The invention will now be illustrated with reference to the following examples. The temperatures are given in degrees centigrade.
  • Example 1:
    • (a) 10 g of racemic 1-(4-ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid and 20 ml of thionyl chloride were heated under reflux for 1 h and the excess thionyl chloride removed in vacuo. The residue was dissolved in dry tetrahydrofuran (50 ml), 6.5 g of 2,3-isopropylidene-D(+)-ribonic acid-1,4-lactone added and the stirred solution colled in ice during the addition of pyridine (3 ml). The mixture was allowed to stand at room temperature overnight. The solvents were removed in vacuo and the residue partitioned between ethyl acetate (150 ml) and water (150 ml). The ethyl acetate layer was washed with 1 M hydrochloric acid (2 x 100 ml), 5% sodium carbonate (1 x 50 ml) and brine (2 x 100 ml) and dried (Na2SO4). Concentration gave a crude mixture of the S(+) and R(-) diastereoisomeric esters of 1-(4-ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid and 2,3-isopropylidene-D(+)-ribonic acid-1,4-lactone (15.5 g).
    • (b) These S(+) and R(-) diastereoisomeric esters were dissolved in a mixture of ethyl acetate and hexane (1:7,120 ml) and cooled to give 5.4 g of fine colourless needles of the ester of S(+)-1-(4-ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid and which was 92% pure by high-performance liquid chromatographic analysis. Recrystallization from ethyl acetate-hexane gave 4.4 g of the pure S(+)-ester, m.p. 108-9°.
      Figure imgb0002
      (c = 1.3, CHCl3).1 H NMR. δ 7.03, 2H,d,J,9Hz;6.72,2H,d,J9Hz;4.51,1H,m;4.2, 3H,m;4.00,1H,m;3.90,2H,J7Hz,q;3.4,1H,m; 2.85, 1 H, m; 1.38, 3H, s; 1.37, 3H, t, J 7 Hz; 1.26, 3H, s. Mass spectrum: M+1 462.1296, C21 H22F4O7 requires 462.1299. The combined mother liquors were chromatographed on silica gel using ethyl acetate-hexane (1 :4) to give 6 g of the pure R(-)-lactone ester, 830 mg of mixed S(+) and R(-) diastereoisomers and a further 860 mg of the pure S(+)-lactone ester. The R(-)-lactone ester crystallized slowly from ether-hexane as large colourless prisms, m.p. 70-1
      Figure imgb0003
      (c = 1.3, CHCl3). 1 H NMR δ 7.10, 2H, d, J 9 Hz; 6.85, 2H, d, J 9 Hz; 4.65, 1 H, m; 4.52, 2H, AB, J 16,4 Hz; 4.32, 2H, m; 3.99,2H, q, J 7 Hz; 1.44, 3H, s; 1.38, 3H, t, J 7 Hz; 1.33, 3H, s. Mass spectrum: measured M+ 462.1296, C21 H22F4O7 requires 462.1299.
    • (c) The pure S(+)-lactone ester (4.5 g) was dissolved in methanol (50 ml) and 10% aqueous sodium hydroxide (9 ml) added. The mixture was heated to 80° until homogeneous and allowed to stand at room temperature overnight. The mixture was acidified to pH 2 with 2M hydrochloric acid and stirred for 2 h to yield a crystalline solid. This solid was extracted into dichloromethane. The dichloromethane extract washed with water, dried (MgS04) and concentrated to give 2.83 g of colourless crystalline S(+)-1-(4-ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid, m.p. 89-91°.
      Figure imgb0004
      (c = 1, EtOH). The1H NMR spectrum was identical to that of the racemic acid.
    • (d) Treatment of the R(-)-lactone ester (112 mg) as described above in Example 1 (c) gave R(-)-1-(4-ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid as a colourless crystalline solid (71 mg), m.p. 89-90°,
      Figure imgb0005
      -94.7° (c = 1.41, CHCI3). The H NMR spectrum was identical to that of the racemic acid.
    Example 2:
    • (a) The racemic acid 1-(4-ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid (0.5 g) was dissolved in benzene (8 ml) and thionyl chloride (1 ml) added and the mixture refluxed for 2 h. The solvent and excess reagent was removed under reduced pressure and the pale-yellow liquid dried under high vacuum. To this liquid was added a benzene (8 ml)-tetrahydrofuran (1 ml) solution of 1,2-isopropylidone-(+)-a-D-glucofuranurono-3,6-lactone (410 mg) and pyridine (0.5 ml). The mixture was allowed to stand for 2 h during which time a crystalline solid formed. Completion of the reaction was checked using thin-layer chromatography (silica gel, petroleum spirit/ethyl acetate 3:1). The reaction mixture was mixed with methylene chlorine and washed with water. Concentration of the dried organic phase gave a very pale syrup (927 mg). The product was further purified by preparative layer chromatography (silica gel, petroleum spirit/ethyl acetate 3:1). In the H NMR spectrum the two diastereoisomeric esters were observed to be present in a ratio of approximately 1:1 as measured from the doublets of proton-5 (8 5.98 and 5.90) of the sugar moiety.
    • (b) A portion of the product from Example 2 (a) (412 mg) was dissolved in methanol (10 ml) and water added until the solution was slightly cloudy. Large colourless needle-like crystals of the ester of R(-)-1-(4-ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid and 2,3-isopropylidene-(+)-a-D-glucofuranurono-3,6-lactone rapidly formed. These were filtered and washed with methanol-water and dried in vacuo (92.3 mg, m.p. 142-4°,
      Figure imgb0006
      (c = 2.15, CHCl3). The1H NMR spectrum showed a single doublet at 8 5.90 for proton-5 of the sugar moiety. Mass spectrum: M+ 490.1245, C22H22F4O8 requires M+ 490.1248. Major fragment ions m/e 475.274 (base), 247, 246, 219, 218.
    • (c) The acid chloride of racemic 1-(4- ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutanoic acid was prepared byrefluxing the acid (50 g) with thionyl chloride (100 ml) for 1.5 h. Excess thionyl chloride was removed in vacuo, the residue dissolved in tetrahydrofuran (100 ml) and 1,2-isopropylidene-(+)-α-D-glucofuranurono-3,6- lactone (41 g) added and the solution stirred until homogeneous. The mixture was cooled in ice, pyridine (20 ml) added with stirring over 15 min and stirring continued at 20° for 3 h. The mixture was partitioned between ethyl acetate (750 ml) and water (700 ml), the ethyl acetate layer washed with 1 M aqueous hydrochloric acid (2 x 200 ml), 5% aqueous sodium carbonate (1 x 300 ml) and water (1 x 300 ml). Evaporation of the dried (MgSO4) ethyl acetate layer gave a semisolid residue to which methanol (500 ml) was added causing partial dissolution to give a highly crystalline precipitate of 80% pure ester of S(+)-1-(4-ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid and 1,2-isopropylidene-(+)-α-D-glucofuranurono-3,6-lactone (34 g) which was removed by vacuum filtration. Recrystallization from methanol yielded pure S(+)-ester, m.p. 178-9°,
      Figure imgb0007
      (c = 1.5, CHCl3). The 1HNMR spectrum showed a single doublet at δ 5.98 with no doublet at δ 5.90 (cf. 1HNMR of R(-)-ester). Mass spectrum: measured M+ 490.1245, C22H22F4O8 requires M+ 490.1248.
    • (d) A portion of the product of Example 2 (b) (43 mg) was dissolved in ethanol (5 ml) and a few drops of 1 M aqueous sodium hydroxide were added. After a few hours the brown solution was acidified with aqueous hydrochloric acid and partitioned between water and methylene chloride. Concentration of the organic phase gave a pale-yellow syrup (25.5 mg). Purification by preparative thin-layer chromatography (silica gel, petroleum spirit/ethyl acetate 4:1) gave R(-)-1-(4-ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid ethyl ester as a colourless liquid (20.7 mg),
      Figure imgb0008
      (c = 1.38, CHCl3). The ethyl ester (20.7 mg) was dissolved in methanol (1 ml) and 10% aqueous sodium hydroxide (2 ml) added and the mixture was heated on the steam bath for a few minutes until homogeneous. After standing (3 h) the homogeneous solution was acidified with aqueous hydrochloric acid and extracted with methylene chloride. The methylene chloride phase was dried and concentrated to give R(-)-1-(4-ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid as a colourless crystalline solid (17.0 mg),
      Figure imgb0009
      (c = 1.13, CHCl3). The 1HNMR spectrum was identical to that of the racemic acid.
    • (e) A portion of the S(+)-ester product of Example 2 (c) (1 g) was dissolved in methanol (20 ml) and 1 M aqueous sodium hydroxide added. The mixture was heated at 60° until no longer turbid and allowed to stand at 20° overnight. Concentrated hydrochloric acid was added to the stirred solution to pH 2 followed by ethyl acetate (20 ml) and the mixture stirred for 2 h. The ethyl acetate layer was extracted with 1 M aqueous sodium hydroxide (2 x 15 ml) and the basic extracts combined and acidified with hydrochloric acid, the precipitated S(+)-1-(4- ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid filtered, washed with water and dried. Recrystallization from hexane gave the pure S(+)-acid m.p. 89-91°,
      Figure imgb0010
      (c = 0.9, CHCl3).
    Example 3:
  • 1.0 g of racemic 1-(4-chlorophenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid was converted to a mixture of the S(+) and R(-) diastereoisomeric esters by conversion to the acid chloride and reaction with 0.7 g of 2,3-isopropylidene-D(+)-ribonic acid-1,4-lactone according to the general method of Example 1 (a) to yield 1.55 g of a gum which was crystallized from ethyl acetate-hexane to give the R (-) -diastereoisomeric lactone ester (0.5 g) which was then recrystallized from ethyl acetate-hexane to give pure material m.p. 123-6°. The R(-)-lactone ester had an
    Figure imgb0011
    (c = 1.4, CHCl3). 1HNMR spectrum: δ (CDCl3) 7.34, 2H, d, J 9 Hz; 7.14,2H, d, J 9 Hz; 4.68, 1 H, m; 4.56, 2H, s; 4.35, 2H, m; 3.50,1 H, m; 2.96, 1H, m; 1.44, 3H, s; 1.35, 3H, s. Mass spectrum: measured M+ -15 437.0410, C18H14 35CIF4O6 requires M+ -15 437.0412. The combined mother liquors were dissolved in a mixture of ethyl acetate and hexane and chromatographed on silica gel using ethyl acetate-hexane (1:4) to give the R(-)-lactone ester of 1-(4-chlorophenyl)-2,2,3,3,-tetrafluorocyclobutane carboxylic acid and 2,3-isopropylidene-D(+)-ribonic acid-1,4-lctone (200 mg), a mixture of diastereoisomers mg) and the corresponding S(+)-isomer (650mg) as an oil,
    Figure imgb0012
    (c = 1.2, CHCl3),1HNMR spectrum:δ (CDCl3) 7.38, 2H,d,J9 Hz;7.22,2H,d,J9Hz;4.65,1H,m;4.2, 4H, m; 3.5, 1H, ; 3.0, 1H, m; 1.42, 3H, s; 1.32, 3H, s. Mass spectrum: measured M 452.0656, C19H17 35CIF4O6 requires 452.0647.
  • Hydrolysis of the two isomeric ribonyl esters prepared as described above gave R(-)-1-(4-chlorophenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acids as colourless crystals from hexane, m.p. 126-8°,
    Figure imgb0013
    (c = 1.8, CHCl3) with the 1HNMR spectrum identical to that of the racemic acid and the corresponding S(+)-acid with m.p. 122-4°,
    Figure imgb0014
    (c = 1.15, CHCl3) with a 1HNMR spectrum identical to that of the racemic acid.
  • Example 4:
  • The mixed diastereoisomeric esters of racemic 1 -(4-bromophenyl)-2,2,3,3-tetraftuorocyclo- butane carboxylic acid and 2,3-isopropylidene-D(+)-ribonic acid-1,4-lactone were prepared from the racemic acid (1.15 g) and the lactone using the general method of Example 1 (a) to yield 1.48 g of ester which was recrystallized from ethyl acetate-hexane to give 0.6 g of the R(-)-ester which, on a second recrystallization from ethyl acetate-hexane, gave colourless needles (0.52 g). The combined mother liquors were chromatographed on silica gel (ethyl acetate/hexane 1 :4) to yield the R(-)-ester (0.16 g), a mixed fraction (0.10 g) and the S(+)-ester as a viscous oil (0.67 g). R(-)-ester, m.p. 134-5°,
    Figure imgb0015
    (c = 1.8, CHCl3). 1HNMR spectrum: δ (CDCl3) 7.45, 2H, d, J 9 Hz; 7.05, 2H, d, J 9 Hz; 4.64, 1 H, m;4.52,2H,s;4.29,2H,m;3.45,1H,m;2.92,1H, m; 1.45, 3H, s; 1.35, 3H, s. Mass spectrum: M -15 480.9906, C18H14Br79O6F4 requires 480.9908. S(+)-ester, a colourless gum
    Figure imgb0016
    +29.5° (c = 1.5, CHCl3). 1HNMR spectrum: δ (CDCl3) 7.44, 2H, d, J 9 Hz; 7.08, 2H, d, J 9 Hz; 4.62,1 H, m; 4.30, 4H, m; 3.45,1 H, m; 2.90,1 H, m; 1.43, 3H, s; 1.32,3H, s. Mass spectrum: measured M+ -15 481.9901, C18H14 79BrO6F4 requires 481.9908. Hydrolysis of the R(-)-ester using the general method of Example 1 (d) gave the R(-)-acid as colourless prisms after recrystallization from hexane, m.p. 121-3°,
    Figure imgb0017
    (c = 1, CHCl3) (reported m.p. 24.5°,
    Figure imgb0018
    [EtOH]) with the 1H NMR spectrum identical to that of the racemic acid. Hydrolysis of the S(+)-ester (84 mg) using the general method of Example 1 (d) gave the S(+)-acid (50 mg) as colourless prisms after recrystallization from hexane, m.p. 122-4°
    Figure imgb0019
    (c = 1.3, CHCl3) (reported m.p. 132-3°
    Figure imgb0020
    [EtOH]) with the 1H NMR spectrum identical to that of the racemic acid.
  • Example 5:
  • Mixed diastereoisomeric esters were prepared from 1-(3,4-methylenedioxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid (0.5g) and 2,3-isopropylidene-D(+)-ribonic acid-1,4-lactone (0.35 g) using the general method of Example 1 (a) to yield 0.8 g of ester which was separated into its pure diastereoisomers by chromatography on silica gel, using ethyl acetate/hexane (1 :3). The less polar R (-) diastereoisomeric ester (350 mg) was obtained as a solid foam,
    Figure imgb0021
    (c = 0.8, CHCl3). 1HNMR spectrum: δ (CDCl3) 6.76, 3H, m; 5.96, 2H, s; 4.70, 1H, m; 4.60,1 H, d, J 6 Hz; 4.50, 1 H, d, J 6 Hz; 4.36, 2H, apparentd, J 2 Hz; 3.4,1 H, bm; 2.9, 1 H, bm; 1.44, 3H, s; 1.36, 3H, s. Mass spectrum: measured M 462.0932, C20H18F4O8 requires M+ 462.0935. The more polar S(+) diastereoisomeric ester crystallized from ethyl acetate-hexane as colourless needles, m.p. 107-10°,
    Figure imgb0022
    (c = 1.4, (CHCl3). 1HNMR spectrum 8 (CDCl3) 6.76, 3H, m;5.97,2H,s;4.64,1H,m;4.4,2H,bs;4.40,1H, d, J 6 Hz; 4.21,1 H, d, J 6 Hz; 3.4,1 H, bm; 2.9,1 H, bm; 1.42, 3H, s; 1.30, 3H, s. Mass spectrum: measured M+ 462.0932, C20H18F4O8 requires M+ 462.0935. Hydrolysis of the R(-) diastereoisomeric ester according to the general method of Example 1 (d) gave R(-)-1-(3,4-methylenedioxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid, m.p. 166-9°,
    Figure imgb0023
    (c = 1, CHCl3). Hydrolysis of the S(+) diastereoisomeric ester (43 mg) according to the general method of Example 1 (d) gave S(+)-1-(3,4-methylenedioxyphenyl)-2,2,3,3-tetrafluorocyclobutane car- boxylicacid (22 mg), m.p. 117-23°,
    Figure imgb0024
    (c=1,CHCl3).
  • Example 6:
  • 1-(4-Ethoxyphenyl)-2,2-dichlorocyclopro- pane carboxylic acid (1 g) was esterified to its mixed diastereoisomers by conversion to the acid chloride and reaction with 2,3-isopropylidene-D(+)-ribonic acid-1,4-lactone (0.71 g) according to the general method of Example 1 (a) to yield 1.53 g of esters. A portion of this product was separated by preparative high-performance liquid chromatography (silica gel, ethyl acetate/hexane 1:3) (10 mg) injections to give two pure diastereoisomers as colourless viscous gums. The more polar isomer had
    Figure imgb0025
    (c = 0.6, CHCl3). 1HNMR spectrum: δ (CDCl3) 7.25, 2H, d, J 9 Hz; 6.86, 2H, d, J 9 Hz; 4.64, 1 H, m; 4.50, 1 H, d, J 6 Hz; 4.32, 3H, m; 4.00, 2H, q, J 6 Hz; 2.56, 1H, d, J 8 Hz; 2.00, 1 H, d, J 7 Hz; 1.46, 3H, s; 1.40, 3H, t, J 7 Hz; 1.35, 3H, s.
  • The less polar isomer had 1HNMR spectrum: δ (CDCI3) 7.27, 2H, d, J 9 Hz; 6.88, 2H, d, J 9 Hz; 4,64,1 H, m; 4.35, 3H, m; 4.04, q, J 7 Hz; 3.90, d, J 6 Hz; 2.59, d, J 7 Hz; 1.99, d, J 7 Hz; 1.40, 3H, s;1.40,3H, t, J 7 Hz;1.26,3H, s. Hydrolysis of the more polar ester gave S(+)-1-(4-ethoxyphenyl)-2,2-dichlorocyclopropane carboxylic acid, m.p. 168-9°,
    Figure imgb0026
    (c = 0.9, CHCI3). The less polar ester gave R(-)-1-(4-ethoxyphenyl)-2,2-dichlorocyclopropane carboxylic acid, m.p. 167-9°,
    Figure imgb0027
    (c = 1, CHCI3). The 1HNMR spectra of both enantiomers were identical to that of the racemate.
  • Example 7:
  • Mixed diastereoisomeric esters were prepared by the general method of Example 1 (a) from 6-chloro-a-methyl-carbazole-2-acetic acid (1.35 g) and 2,3-isopropylidene-D(+)-ribonic acid-1,4-lactone (0.94 g) to give 1.97 g of product. A portion of this product was separated by chromatography on silica gel (ethyl acetate/hexane 1:2) to yield the less polar (-) diastereoisomeric ester as a white solid, m.p. 132-4°,
    Figure imgb0028
    (c = 1.4, CHCI3). The more polar (+) diastereoisomeric ester crystallized from ethyl acetate-hexane as fine needles, m.p. 144-7°,
    Figure imgb0029
    (c = 1.2, CHCl3). Slow evaporation of a solution of the mixed diastereoisomeric ester in ethyl acetate-hexane gave pure crystals of the more polar (+) diastereoisomeric ester. Hydrolysis of the more polar (+) diastereoisomeric ester gave (-)6-chloro-α-methyl-carbazole-2-acetic acid,
    Figure imgb0030
    (c = 0.9, CH3COCH3).
  • Example 8:
  • Racemic 8-chloro-a-methyl-3-dibenzofuran- acetic acid (2.7 g) and 2,3-isopropylidene-D(+)-ribonic acid-1,4-lactone (1.88 g) gave, by the general method of Example 1 (a), 4.03 g of mixed diastereoisomeric esters which were readily separated by silica gel chromatography (ethyl acetate/hexane 1 :3) to yield the less polar (-) isomer (1.96 g) as a colourless gum ([α]D -34.9° [c = 1, CHCL3]; partial 1HNMR spectrum: 8 [CDCl3] 1.53, 3H, d, J 8 Hz; 1.32, 3H, s; 1.01, 3H, s) and the more polar isomer as a colourless solid which was crystallized from ether-hexane to yield needles, m.p. 111-2°, [α]D -14.9° (c = 1, CHCl3); partial 'HNMR spectrum: δ (CDCl3) 1.56, 3H, d, J 8 Hz; 1.37, 3H, s; 1.24,3H, s.
  • Example 9:
  • To a solution of 2,3-isopropylidene-D(+)-ribono-1,4-lactone (1.88 g) in drytetrahydrofuran (10 ml) was added 2-chloropropionyl chloride (1.27 g) followed by dry pyridine (0.79 g). Pyridine hydrochloride was immediately precipitated and, after standing at room temperature for 1 h, the reaction mixture was diluted with diethyl ether (20 ml). The ethereal solution was partitioned with 1 M HCI (2 x 10 ml), water (2 x 10 ml) and then dried over magnesium sulfate. Removal of the ether in vacuo gave a crystalline solid (2.8 g), part of which was resolved into two pure diastereoisomers by high-performance liquid chromatography (ethyl acetate/hexane 1:1). The less polar diastereoisomer was recrystallized from ether-hexane to give colourless prisms, m.p. 54.2.55°,
    Figure imgb0031
    (c = 1, CHCl3).1HNMR spectrum: 8 (CDCI3) 4.80, 3H, m; 4.35, 3H, m; 1.67, 3H, d, J 8 Hz; 1.48, 3H, s; 1.40, 3H, s. Mass spectrum: M+ -15, 263, C10H12ClO6 requires 263. The more polar isomer was recrystallized from diethyl ether-hexane to give colourless prisms, m.p. 64.5-65°,
    Figure imgb0032
    (c = 1, CHCl3). 1HNMR spectrum: δ (CDCl3) 4.80, 3H, m; 4.40, 3H, m; 1.68, 3H, d, J 8 Hz; 1.48, 3H, s; 1.40,3H, s.
  • Example 10:
  • A solution of 2,3-isopropylidene- D (+)-ribono-1,4-lactone (188 mg) and 2-phenylbutyric anhydride (310 mg) in d5-pyridine (0.35 ml) was monitored by1 HNMR until reaction was complete (1.5 h). The mixture was dissolved in diethyl ether (20 ml), partitioned with aqueous hydrochloric acid (2 x 20 ml, 1 M) and aqueous sodium hydroxide (2 x 10 ml, 1 M). The combined alkaline extracts were acidified with 1 OM hydrochloric acid to pH 2, extracted with diethyl ether (2 x 10 ml) and the dried (MgSO4) ether extracts concentrated in vacuo to give (+)-2-phenylbutyric acid (150 mg),
    Figure imgb0033
    (c = 1.0, benzene).
  • Example 11:
  • A mixture of racemic cis/trans-2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropane carboxylic acids (2.09 g) was reacted with 2,3-isopropylidene-D(+)-ribonic acid-1,4-lactone (1.88 g) using the general method of Example 1 (a) to give a mixture of four esters (3.7 g). This mixture was allowed to stand at room temperature for 5 d during which time it crystallized. The solid mass was triturated with diisopropyl ether (20 ml) and the undissolved solid collected by filtration to yield an approximately 1:1 mixture of the esters of the cis and trans (-)-1S-acids (1.2 g). A further portion of this mixture was separated by high-performance liquid chromatography on silica gel into pure trans-(-)-1S and cis-(+)-1R esters (ethyl acetate/hexane 1:2.5). A portion of the mother liquors was also separated under the same conditions to give pure samples of the four esters.
  • The cis-(+)-1 R ester crystallized from diisopropyl ether-hexane as colourless plates, m.p. 121.5-23°,
    Figure imgb0034
    (c = 1, CHCI3). 1HNMR spectrum: 8 (CDCl3) 6.10,1 H, d, J 8 Hz; 4.70,3H, m; 4.28, 2H, m; 2.07, dd, J 8,8 Hz; 1.72, 1 H, d, J 8 Hz; 1.48, 3H, s; 1.40, 3H, s; 1.24, 6H, s. The trans-(+)-1 R ester crystallized from diisopropyl ether-hexane as colourless prisms, m.p. 89.5-91 °;
    Figure imgb0035
    (c = 1, CHCl3).1HNMR spectrum: 8 (CDCl3) 5.56, 1 H, d, J 8 Hz; 4.64, 3H, m; 4.30, 2H, m; 2.20, 1 H, dd, J 8,6 Hz; 1.54, 1H, d, J 6 Hz; 1.47, 3H, s; 1.38, 3H, s; 1.24, 3H, s; 1.18, 3H, s. The cis-(-)-1 S ester crystallized from diisopropyl ether as needles, m.p. 129-30°,
    Figure imgb0036
    (c = 1, CHCl3). 1HNMR spectrum: δ (CDCl3) 6.08, 1 H, d, J 8 Hz; 4.70,3H, m; 4.24, 2H, m; 2.07, 1H, dd, J 8,8 Hz; 1.72, 1H, d, J 8 Hz; 1.48,3H, s; 1.38, 3H, s; 1.25, 6H, s. The trans-(-)-1S ester cristallized from diisopropyl ether-hexane as colourless needles, m.p. 101.5-03°,
    Figure imgb0037
    (c = 1, CHCl3). 1HNMR spectrum: δ (CDCl3) 5.56, 1 H, d, J 8 Hz; 4.70, 3H, m; 4.28, 2H, apparent d, J 2 Hz; 2.10, 1 H, dd, J 8, 6 Hz; 1.48, 3H, s; 1.38, 3H, s; 1.26, 3H, s; 1.19, 3H, s.
  • Example 12:
  • Racemic 1 - (4-ethoxyphenyl) -2,2,3,3-tetrafluorocyclobutane carboxylic acid (10 g) and thionyl chloride (5 ml) was heated under reflux for 2 h and excess thionyl chloride removed in vacuo. The residue was dissolved in dry tetrahydrofuran (25 ml), 4.45 g of D(-)-pantolactone added and the stirred solution cooled ice during the addition of pyridine (3 ml). The mixture was allowed to stand at room temperature for 2 h. The solvents were removed in vacuo and the residue was chromatographed on silica gel using ethyl acetate- hexane (1 :5) to give 5.3 g of the R(-)-lactone ester of 1-(4-ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid and D(-)-pantolac- tone, 2.9 g of mixed diastereoisomeric lactone esters (~1:2 [-]:[+]) and 4.3 g of the corresponding S(+)-lactone ester. The R(-)-lactone ester crystallized on standing and was recrystallized from hexane as large needles, m.p. 73-4°;
    Figure imgb0038
    (c = 1.7, CHCL3); ' 1HNMR spectrum: δ (CDCI3) 7.20, 2H, d, J 9 Hz; 6.85, 2H, d, J 9 Hz; 5.23, 1 H, s; 3.98, 2H, q, J 7 Hz; 3.94, 2H, s; 3.45, 1 H, m; 3.05, 1 H, m; 1.38, 3H, t, J 7 Hz; 1.16, 3H, s; 1.06, 3H, s. Mass spectrum: M+ 404.1237, C19H20O5F4 requires 404.1244. The S(+)-lactone ester was a colourless syrup;
    Figure imgb0039
    +71.0° (c = 1.5, CHCl3); 1H NMR spectrum: δ (CDCl3) 7.20, 2H, d, J 9 Hz; 6.85, 2H, d, J 9 Hz; 5.20, 1 H, s; 3.98, 2H, q, J 7 Hz; 3.88, 2H, s; 3.45, 1 H, m; 3.05, 1 H, m; 1.38, 3H, t, J 7 Hz; 1.02, 3H, s; 0.89, 3H, s. The R(-)-ester (3.55 g) was mixed with methanol (10 ml) and 10% aqueous NaOH (7 ml) and stirred overnight give a homogeneous solution. After dilution with water (75 ml) the solution was acidified with 2M aqueous HCI and extracted with CH2Cl2. Concentration of the CH2Cl2 gave a colourless crystalline solid (2.53 g),
    Figure imgb0040
    (c = 1.3, EtOH) with a 1HNMR spectrum identical to the racemic acid. The S(+)-ester (3.76 g) was treated as above to gives a colourless crystalline solid (2.43 g), [α]29 D +91.0° (c = 1.6, CHCl3) with a 1H NMR spectrum identical to the racemic acid.
  • Example 13:
  • 1 - -(4-Ethoxyphenyl)-2,2-dichlorocyctopro- pane carboxylic acid (10 g) was heated with thionyl chloride (5 ml) for 1.5 h and the excess thionyl chloride removed in vacuo. To the residue was added a solution of D(―)-pantolactone (5 g) in dry tetrahydrofuran (20 ml) followed by pyridine (4 ml). The mixture was allowed to stand at room temperature for 2 h and was then partitioned between benzene (100 ml) and 1 M aqueous hydrochloric acid (100 ml). The benzene layer was then washed water (100 ml), 10% aqueous sodium carbonate (100 ml) and water (100 ml), then dried over magnesium sulfate. Concentration gave the crude mixture of diastereoisomeric lactone esters of 1-(4-ethoxyphenyl) -2,2-dichlorocyclopropane carboxylic acid and D(-)-pantolactone (13.74 g). The diastereoisomeric lactone esters were dissolved in hexane and cooled to give dense crystals (5.43 g) of the lactone ester of S(+)-1-(4-ethoxyphenyl)-2,2-dichlorocyclopropane carboxylic acid of greater than 90% purity. Recrystallization from hexane gave the pure S(+)-lactone ester, m.p. 118°;
    Figure imgb0041
    (c = 1.2, CHCl3); 1HNMR spectrum: δ (CDCl3) 7.32, 2H, d, J 9 Hz; 6.83, 2H, d, J 9 Hz; 5.25,1 H, s; 3.98, 2H, q, J 7 Hz; 3.92, 2H, s;2.61,1H,d,J8Hz;2.05,1H,d,J8Hz;1.38,3H, t, J 7 Hz; 1.05, 3H, s; 0.87, 3H, s. Mass spectrum: M+ 386.0682, C18H20O5
    Figure imgb0042
    requires 386.0687. The mother liquors from the crystallization of the S(+)-lactone ester were partially concentrated and on standing at room temperature gave colourless needles (3.76 g) of the lactone ester of R(-)-1-(4-ethoxyphenyl)-2,2-dichlorocyclo- propane carboxylic acid of greater than 90% purity. Recrystallization from hexane gave pure R(-)-lactone ester, m.p. 95-6°;
    Figure imgb0043
    (c = 1.0, CHCl3); 1HNMR spectrum: δ (CDCl3) 7.32, 2H, d, J 9 Hz; 6.84, 2H, d, J 9 Hz; 5.27, 1H, s; 4.00, 2H, q, J 7 Hz; 3.97, 2H, s; 2.61,1H, d, J 8 Hz; 2.08,1H, d,J8Hz;1.37,3H,t,J7Hz;1.19,3H,s;1.14,3H, s. Mass spectrum: M+ 386.0678, C18H20O5
    Figure imgb0044
    requires 386.9687. The R(-)-ester (3.40 g) was mixed with methanol (15 ml) and 10% aqueous NaOH (10 ml) and heated at 100° until homogeneous. After standing overnight, water (100 ml) was added and the mixture was acidified with 1 M aqueous HCI and extracted with CH2CI2. Concentration of the CH2CI2 gave a colourless crystalline solid (2.54 g),
    Figure imgb0045
    (c = 1, CHCl3) with a HNMR spectrum identical to the racemic acid.
  • Example 14:
  • To a solution of the D(-)-pantolactone (0.7 g) in tetrahydrofuran (5 ml) was added 2-chloropropionyl chloride (0.7 g) followed by dry pyridine (0.5 ml). Pyridine hydrochloride was immediately precipitated and, after standing for 1.5 h, the reaction mixture was filtered and the filtrate on concentration gave the crude mixture of diastereoisomeric lactone esters. The mixture of diastereoisomeric lactone esters was chromatographed on silica gel using ethyl acetate-hexane (1 :3) to give 0.18 g of the less polar diastereoisomeric lactone ester, 0.97 g of a mixture of the two diastereoisomeric lactone esters and 0.015 g of the more polar diastereoisomeric lactone ester. The less polar diastereoisomeric lactone ester was a colourless liquid;
    Figure imgb0046
    (c = 0.8, CHCl3); 1HNMR spectrum: δ (CDCL3) 5.34, 1 H, s; 4.50, 1 H, q, J 7 Hz; 4.02, 2H, s;1.73, 3H, d, J 7 Hz; 1.24, 3H, s;1.16, 3H, s. The more polar diastereoisomeric lactone ester was a colourless liquid;
    Figure imgb0047
    (c = 1.5, CHCl3); 1HNMR spectrum: δ (CDCl3 5.31,1 H, s; 4.50, 1H, q, J 7 Hz; 4.03, 2H, s; 1.75, 3H, d, J 7 Hz; 1.23,3H, s; 1.15, 3H, s. The lactone esters were hydrolysed using the general method of Example 1 (c) to give pure R(-)- and S(+)-2-chloropropionic acids.
  • Example 15:
  • Trans-2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropane carboxylic acid (0.8 g) and thionyl chloride (0.5 ml) were heated at 100° for 1.5 h and excess thionyl chloride removed in vacuo. D(-)-pantolactone (0.5 g) dissolved in dry tetrahydrofuran was added to the resulting acid chloride followed by pyridine (0.4 ml). After 2 h the reaction mixture was partitioned between benzene (20 ml) and 1 M aqueous hydrochloric acid and the organic layer washed with water (20 ml), 10% aqueous sodium carbonate (20 ml) and water (20 ml) then dried with magnesium sulfate. The solvents were removed in vacuo and the residue dissolved in diisopropyl ether. On standing at room temperature colourless plates (0.50 g) of the lactone ester of the R(+)-trans-2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropane carboxylic acid formed which were 84% pure. Recrystallization from diisopropyl ether gave pure R(+)-trans- lactone ester as colourless plates, m.p. 124-5°;
    Figure imgb0048
    (c = 1, CHCl3);1HNMR spectrum: δ (CDCl3) 5.62, 1 H, d, J 8 Hz; 5.32, 1 H, s; 4.00, 2H, s; 2.27, 1 H, dd, J 8 Hz, J 5 Hz; 1.72, 1H, d, J 5 Hz; 1.35, 3H, s; 1.24, 6H, s; 1.15, 3H, s. Mass spectrum: M+ 320.0578, C14H18O4
    Figure imgb0049
    requires 320.0581. Separation by preparative high-performance liquid chromatography (ethyl acetate/hexane 1 :3) gave the S(-)-trans-ester which was recrystallized from hexane to give colourless crystals, m.p. 68-70°,
    Figure imgb0050
    (c = 1.1, CHCl3). ' 1HNMR spectrum: 5.55, 1 H, d, J 8 Hz; 5.28, 1H, s; 3.96, 2H, s; 2.28, 1H, dd, J 8 Hz; J 5 Hz; 1.72, 1 H, d, J 5 Hz; 1.30, 3H, s; 1.22, 3H, s; 1.18, 3H, s; 1.09, 3H, s. Mass spectrum: M+ -35 285.0891, C14,H18O4Cl35 requires 285.0892. The lactone ester was hydrolysed using the general method of Example 1 (c) to give pure R(+)-trans-2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropane carboxylic acid.
  • Example 16:
  • Cis-2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropane carboxylic acid (0.8 g) (containing 5% of the corresponding trans-acid as an impurity) was converted to a crude mixture of diastereoisomers using the general method of Example 15. The mixture (1.19 g) was dissolved in hexane and on standing at room temperature gave colourless needles (0.25 g) of the lactone ester of R(+)-cis-2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropane carboxylic acid containing 17% of the R(+)-trans-ester as an impurity. Separation by preparative high-performance liquid chromatography (ethyl acetate/hexane 1:4) gave the R(+)-cis-lactone ester which was recrystallized from hexane as colourless needles, m.p. 109°,
    Figure imgb0051
    (c = 0.6, CHCl3),' HNMR spectrum: 8 (CDCl3) 6.10, 1H, d, J 8 Hz; 5.25, 1 H, s; 3.96, 2H, s; 2.08, 1 H, dd, J 8 Hz; 1.95, 1 H, d, J 8 Hz; 1.29, 3H, s; 1.26, 3H, s; 1.18, 3H, s; 1.10, 3H, s. Mass spectrum: M+ -35 285.0893, C, 4,H18O4Cl35 requires 285.0892. Separation by preparative high-performance liquid chromatography (ethyl acetate/hexane 1:3) gave the S(-)-cis-ester which was isolated as a colourless liquid containing 15% of the mixed trans-esters ,
    Figure imgb0052
    (c=1.8,CHCl3),1HNMRspectrum: 8 (CDCI3) 6.17, 1 H, d, J 8 Hz; 5.29, 1 H, s; 4.00, 2H, s; 2.14,1 1 H, s; 1.97, 1 H, d, J 8 Hz; 1.30, 3H, s; 1.26, 3H, s; 1.20, 3H, s; 1.10, 3H, s. Mass spectrum: M+ 320.0581, C14H18O4
    Figure imgb0053
    requires 320.0581. The lactone ester was hydrolysed using the general method of Example 1 (c) to give pure R(+)-cis-2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropane carboxylic acid.
  • Example 17:
  • Cis/trans-2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropane carboxylic acid (3.3 g) (cis/trans 2:3) was converted to a crude mixture of diastereoisomers (5.0 g) (cis/trans 1:2 by 1 H N M R) using the general method of Example 15. The mixture (5 g) was dissolved in diisopropyl ether, filtered through celite and the filtrate concentrated to 25 ml and 25 ml of hexane added. Cooling to 0° gave pale-brown mica-like plates (1.4 g) consisting of the R(+)-trans-ester 80% and the R(+)-cis-ester 20%.
  • Example 18:
    • (a) 1,4,5,6,7,7-Hexachloro-8,9,10-trinorborn-5-ene-2-carboxylic acid (10 g) was heated with thionyl chloride (10 ml) for 1.5 h at 100° and the excess reagent was removed in vacuo. To the residue was added a tetrahydrofuran (50 ml) solution of 2,3-isopropylidene-D(+)-ribonic acid-1,4-lactone (5.46 g) and then pyridine (3 ml) was added slowly to the solution. A colourless crystalline solid formed and the mixture was left standing for 3 h. The mixture was filtered and the crystal washed with tetrahydrofuran and the filtrate evaporated under reduced pressure and the residue mixed with ethyl acetate and washed with 1 M aqueous hydrochloric acid saturated with sodium chloride and then saturated aqueous sodium chloride and the ethyl acetate phase was evaporated under reduced pressure. The residue was subjected to column chromatography on silica gel (Merck Kieselgel H) using ethyl acetate- hexane (1 :4) to separate the two diastereoisomeric lactone esters of 2,3-isopropylidene-D(+)-ribonic acid-1,4-lactone and of 1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-ene-2-carboxylic acid: the (-)-lactone ester (5.03 g) mixed diastereoisomeric lactone esters (0.41 g) and the (+)-lactone ester (3.77 g).
    • (b) The crystalline (-)-lactone ester was recrystallized from hexane-ethyl acetate to give colourless plates (4.69 g), m.p. 129-33°,
      Figure imgb0054
      -47.3° (c = 2.8, CHCI3). 'HNMR spectrum: δ (CDCI3) 4.92, 1 H, d, J 6 Hz; 4.76, 2H, m; 4.46, 1 H, dd, J 12 Hz, J 2.5 Hz; 4.20, 1 H, dd, J 12 Hz, J 2.5 Hz; 3.58,1 H, dd, J 5 Hz, J 8 Hz; 2.62, 2H, m; 1.49, 3H, s; 1.40, 3H, s. Mass spectrum: measured M+ -15 496.8691, C15H11O6
      Figure imgb0055
      requires 496.8687. The crystalline (+)-lactone ester was recrystallized from hexane-ethyl acetate to give colourless plates (3.41 g), m.p. 136-43°,
      Figure imgb0056
      +13,6° (c = 2, CHCI3). 1HNMR spectrum: 8 (CDCI3) 4.85, 1 H, d, J 6 Hz; 4.73, 2H, m; 4.32, 2H, m; 3.60, 1 H, dd, J 5 Hz, J 8 Hz; 2.62, 2H, m; 1.49, 3H, s;1.40, 3H, s. Mass spectrum: measured M+ -15 496.8691, C15H11O6
      Figure imgb0057
      requires 496.8687.
    • (c) The (-)-lactone ester (3.58 g) was dissolved in a mixture of methanol (25 ml) and 10% aqueous sodium hydroxide (7 ml). After standing overnight, water (150 ml) was added to give a homogeneous solution. On acidification with 1 M hydrochloric acid a white solid precipitated (2.17 g) which was recrystallized from hexane to give colourless crystals of (-)-1,4,5,6,7,7-hexa- chloro-8,9,10-trinorborn-5-ene-2-carboxylic acid, m.p. 159-86° decomp.,
      Figure imgb0058
      (c = 5.5, CHCl3),' 1HNMR spectrum identical to the racemic acid.
    • (d) The (+)-lactone ester (2.54 g) was dissolved in a mixture of methanol (15 ml) and 10% aqueous sodium hydroxide (5 ml). After standing overnight, water was added to give a homogeneous solution. On acidification with 1 M aqueous hydrochlorid acid a white solid precipitated (1.56 g) which was recrystallized from hexane to give colourless crystals of (+)-1,4,5,6,7,7-hexa- chloro-8,9,10-trinorborn-5-ene-2-carboxylic acid, m.p. 159-86° decomp.,
      Figure imgb0059
      (c = 5.6, CHCl3),' 1HNMR spectrum identical to the racemic acid.
  • 1,4,5,6,7,7-Hexachloro-8,9,10-trinorborn-5- ene-2-carboxylic acid may be prepared as follows:
  • A mixture of hexachloropentadiene (137.3 g) and methyl acrylate (43.3 g) was heated at 90-5° for 24 h with stirring under reflux to give methyl 1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-ene-2-carboxylate (180.6 g) as a colourless liquid. 1 HNMR spectrum: 8 (neat) 3.67, 3 H, s; 3.56,1 1 H, m; 2.58, 2H, m. Mass spectrum: measured M+ 355.8497, C9H6O2
    Figure imgb0060
    requires 355.8497.
  • The methyl ester (180 g) was dissolved in methanol (625 ml) and 10% aqueous sodium hydroxide (530 ml) was added and the mixture was stirred overnight at room temperature to give a brown solution. Most of the methanol was removed by evaporation under reduced pressure and the aqueous residue was acidified with 2M HCI and extracted with CH2Cl2; evaporation of the CH2Cl2 gave a crystalline residue of 1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-ene-2-carboxylic acid which was recrystallized from hexane as colourless crystals (67 g), m.p. 156-70° decomp. 1 HNMR spectrum: 8 (CDCI3) 9.60,1 H, br.s; 3.65, 1 H, dd, J 5 Hz, J 8 Hz; 2.65, 2H, m. Mass spectrum: measured M+ 341.8341, C8H4O2
    Figure imgb0061
    requires 341.8340.
  • Example 19:
  • 1,4,5,6,7,7-Hexachloro-8,9,10-trinorborn-5- ene-2-carboxylic acid (10 g) was heated with thionyl chloride (10 ml) at 100° for 1.5 h and the excess thionyl chloride removed in vacuo. To the residual liquid was added a tetrahydrofuran (50 ml) solution of L(+)-pantolactone and pyridine (3.5 ml) added slowly to the solution to be stirred. After 3 h the crystalline solid that had formed was filtered and washed with tetrahydrofuran and the filtrate concentrated under reduced pressure. The residue was mixed with benzene (200 ml) and washed with 1 M aqueous hydrochloric acid, saturated with sodium chloride, saturated aqueous sodium chloride, 10% aqueous sodium carbonate and saturated aqueous sodium chloride. Removal of the solvent under reduced pressure gave a colourless syrup (12.32 g). Crystallization of the syrup from hexane-ethyl acetate (5:1 ) gave the separate diastereoisomeric esters of 1,4,5,6,7,7-hexachloro-8,9,10-trinor- born-5-ene-2-carboxylic acid and L(+)-2-hydroxy-3,3-dimethyl-1,4-butyrolactone. Initial crystallization of the diastereoisomeric esters gave large colourless needles of the (-)-ester and concentration of the filtrate gave large colourless hexagonal crystals of the (+)-ester. The colourless needles of the (-)-ester (4.81 g) had m.p. 152-4°, [α]26 D-10.0° (c = 1.1, CHCl3).' 1HNMR spectrum: δ (CDCI3) 5.28, 1 H, s; 4.03, 2H, 2; 3.77, 1 H, dd, J8Hz,J5Hz;2.70,2H,m;1.22,3H,s,1.14,3H,s. Mass spectrum measured M+ 453.8864, C14H12O4
    Figure imgb0062
    requires 453.8865. Hydrolysis of the (-)-ester using the general method described in Example 18 gave the (-)-acid as colourless crystals.
  • Figure imgb0063
    The colourless hexagonal crystals of the (+)-ester (4.63 g) had m.p. 165°, (c = 1.3, CHCl3). 1HNM R: δ (CDCl3) 5.35,1 H, s; 4.04, 2H, s; 3.80, H, dd, J 8 Hz, J 5 Hz; 2.70, 2H, m; 1.25, 3H, s; 1,24, 3H, s. Mass spectrum: measured M+ 453.8860, C14,H12O4
    Figure imgb0064
    requires 453.8865. Hydrolysis of the (+)-ester using the general method described in Example 18 gave the (+)-acid as colourless crystals.
  • Example 20:
  • Racemic 1-(4-ethoxyphenyl)-2,2-dichloro- cyclopropane carboxylic acid (10.0 g) and thionyl chloride (5 ml) were heated at 100° under reflux for 2 h and the excess thionyl chloride removed in vacuo. To the residue was added a solution of L(+)-2-hydroxy-3,3-dimethyl-1,4-butyrolactone (5 g) in drytetrahydrofuran (20 ml) followed by pyridine (4 ml). The mixture was allowed to stand at room temperature for 2 h then was partitioned between benzene (100 ml), and 1 M aqueous hydrochloric acid saturated with sodium chloride (100 ml). The benzene layer was then washed with saturated aqueous sodium chloride (100 ml), 10% aqueous sodium carbonate Na2CO3 (100 ml) and saturated aqueous sodium chloride (100 ml), then dried over magnesium sulfate. Concentration gave the crude mixture of diastereoisomeric lactone esters of 1-(4-ethoxyphenyl)-2,2-dichlorocyclopropane carboxylic acid and L(+)-2-hydroxy-3,3-dimethyl-1,4- butyrolactone (12.43 g). Crystallization from hexane gave colourless crystals of the R(-)-lactone ester (5.62 g) which were recrystallized from hexane-ethyl acetate to give colourless crystals (3.30 g), m.p. 119°, [α]26 D -89.5° (c = 1.2, CHCl3).1HNMR spectrum identical to the (+) enantiomer given in Example 13. Crystallization of the concentrated filtrate gave colourless crystals of the S(+)-lactone ester (3.80 g), m.p. 96°, [α]28 D + 77.1° (c = 1.4, CHCI3). 'HNMR spectrum identical to the (-) enantiomer given in Example 13. The R(-)-lactone ester (3.30 g) was mixed with methanol (15 ml) and 10% aqueous NaOH (10 ml) and heated at 100° until homogeneous. After standing overnight, water (100 ml) was added and the mixture was acidified with 1 M aqueous hydrochloric acid and extracted with methylene dichloride. Concentration of the methylene dichloride gave colourless crystalline solid R(―)-1-(4-ethoxyphenyl)-2,2-dichtoro- cyclopropane carboxylic acid (2.20 g), [α]28 D -96.6° (c = 1.1, CHCI3) with a1HNMR spectrum identical to that of the racemic acid. The S(+)-lactone ester (2.09 g) was treated as described above to give S(+)-1-(4-ethoxyphenyl)-2,2-dichlorocyclopropane carboxylic acid as a colourless crystalline solid (1.50 g), [α]28 D +93.4° (c = 1.8, CHCI3) with a 1HNMR spectrum identical to that of the racemic acid.
  • Example 21:
  • Racemic 1-(4-bromophenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid (1.0 g) and thionyl chloride (0.5 ml) were heated under reflux at 100° for 2 h and the excess thionyl chloride removed in vacuo. The residue was dissolved in dry tetrahydrofuran (5 ml), L(+)-2-hydroxy-3,3-dimethyl-1,4-butyrolactone (0.4 g) was added and the solution cooled in ice during the addition of pyridine (0.4 ml). The mixture was allowed to stand at room temperature for 2 h. The solvents were removed in vacuo and the residue chromatographed on silica gel using ethyl acetate-hexane (2:5) to give the mixed diastereoisomeric lactone esters of 1-(4-bromophenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid and L(+)-2-hydroxy-3,3-dimethyl-1,4-butyrolactone (1.33 g). Crystallization from hexane gave colourless crystals of the S(+)-lactone ester (0.28 g), m.p. 121-2°,
    Figure imgb0065
    (c = 1.3, CHCI3). 1HNMR spectrum: 8 (CDCI3) 7.46, 2H, d, J 8 Hz; 7.22, 2H, d, J 8 Hz; 5.24, 1 H, s; 3.95, 2H, s; 3.50, 1 H, m; 3.00, 1 H, m; 1.16, 3H, s; 1.07, 3H, s. Mass spectrum: measured M+ 438.0085, C17H15O4Br79F4 requ ires 438.0087. Hydrolysis of the S (+) -lactone ester using the general method of Example 20 gave the S(+)-acid as colourless crystals. Crystallization of the concentrated filtrate gave colourless crystals of the R(-)-lactone ester, m.p. 58-60°,
    Figure imgb0066
    (c = 1.2, CHCl3).1HNMR spectrum: 7.47, 2H, d, J 8 Hz; 7,19, 2H, d, J 8 Hz; 5,23,1 1 H, s; 3.95, 2H, s; 3.60, 1H, m; 3.50, 1H, m; 1.07, 3H, s; 0.93, 3H, s. Mass spectrum: measured M+ 438.0085, C17H15O4Br79F4 requires 438.0087. Hydrolysis of the R(-)-lactose ester using the general method of Example 20 gave the R (-) -acid as colourless crystals.
  • Example 22:
  • Racemic 2-(4-chlorophenoxy)-3-methylbutanoic acid (1.0 g) and thionyl chloride (1 ml) were heated under reflux at 100° for 2 h and excess thionyl chloride removed in vacuo. The residue was dissolved in dry tetrahydrofuran (5 ml), L(+)-2-hydroxy-3,3-dimethyl-1,4-butyrolactone (0.65 g) was added and the solution cooled in ice during the addition of pyridine (0.5 ml). The mixture was allowed to stand at room temperature for 2 h. The solvents were removed in vacuo and the residue chromatographed on silica gel using ethyl acetate-hexane (1:3) to give the mixed diastereoisomeric lactone ester (1.22 g), of 2-(4-chlorophenoxy)-3-methylbutanoic acid and L(+)-2-hydroxy-3,3-dimethyl-1,4-butyrolactone. Crystallization from hexane gave colourless crystals of the (-)-lactone ester (0.36 g), m.p. 137-9°,
    Figure imgb0067
    (c = 1, CHCl3). 1HNMR spectrum: 8 (CDCI3) 7.17, 2H, d, J 8 Hz; 6.82, 2H, d, J 8 Hz; 5.35,1 H, s; 4.47,1 H, d, J 5 Hz; 3.99, 2H, s; 2.35,1 H, m;1.16-1.10,12H, m. Mass spectrum: measured M+ 340.1077, C17H21O5Cl35 requires 340.1075. The (-)-lactone ester (0.18 g) was dissolved in methanol (1 ml) and 10% aqueous sodium hydroxide (0.5 ml) added and the mixture was heated at 50° for 2 h. The solution was then diluted with water (20 ml), acidified with 1M aqueous hydrochloric acid and extracted with methylene chloride. Removal of the solvent in vacuo gave colourless solid crystals of (-)-2-(4-chlorophenoxy)-3-methylbutanoic acid,
    Figure imgb0068
    -31.3° (c = 1.6, CHCI3). 'HNMR spectrum identical to that of the racemic acid.
  • Example 23:
    • (a) Racemic 1-(4-ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid (1.0 g) and thionyl chloride (1 ml) were heated under reflux at 100° for 2 h and excess thionyl chloride removed in vacuo. The residue was dissolved in dry tetrahydrofuran (5 ml), 3,4-isopropylidene-L-arabino-1,5-lactone (0.64 g) was added and the solution cooled in ice during the addition of pyridine (0.5 ml). The mixture was allowed to stand at room temperature for 2 h. The solvents were removed in vacuo and the residue chromatographed on silica gel using ethyl acetate-hexane (2:7) to give crystalline R(-)-lactone ester (0.63 g) and crystalline S(+)-lactone ester (0.48 g) of 1-(4- ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid and 3,4-isopropylidene-L-arabi- no-1,5-lactone. Recrystallization of the R(-)-lactone ester from ethyl acetate-hexane gave colourless needles (0.29 g), m.p. 125-6°,
      Figure imgb0069
      -25.6° (c = 2, CHCl3). 1HNMR spectrum: 8 (CDCI3) 7.20, 2H, d, J 8 Hz; 6.85, 2H, d, J 8 Hz; 5.33,1 H, m; 4.40, 4H, m; 3.98, 2H, q, J 7 Hz; 3.50, 1 H, m: 3.00,1 H, m; 1.45,3H, s; 1.43,3H, t, J 7 Hz; 1.34, 3H, s. Mass spectrum: measured M+ 462.1296, C2, H22O7F4 requires 462.1299. Recrystallization of the S (+) -lactone ester from ethyl acetate-hexane gave colourless needles (0.30 g, m.p.114°,
      Figure imgb0070
      (c = 2.3, CHCl3). 1HNMR spectrum: 8 (CDCI3) 7.20, 2H, d, J 8 Hz; 6.85, 2H, d, J 8 Hz; 5.27,1 H, m; 4.34,4H, m; 3.98,2H, 1, J 7 Hz; 3.50, 1 H, m; 3.00, H, m; 1.45,3H, t, J 7 Hz; 1.41, 3H, s;1.29, 3H, s. Mass spectrum: measured M+ 462.1287, C21 H22O7F4 requires 462.1299.
    • (b) The R(-)-lactone ester (85.4 mg) was dissolved in hot methanol (2 ml) and 10% aqueous sodium hydroxide (1 ml) added to give a homogeneous solution. Water (2 ml) was added to the solution and the homogeneous solution left standing overnight, then water was added (50 ml). Acidification with 1 M aqeous hydrochloric acid gave colourless crystals of R(-)-1-(4-ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid (41.2 mg),
      Figure imgb0071
      (c = 1.4, CHCI3). 1HNMR spectrum identical to the racemic acid.
    • (c) The S(+)-ester (93.4 mg) was treated as above to give colourless crystals of S(+)-1-(4- ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid (44.4 mg),
      Figure imgb0072
      (c = 1.5, CHCl3). 1HNMR spectrum identical to the racemic acid.
    Example 24:
  • Potassium L-arabonate (11.4 g) (prepared by the method of P. Andrews, L. Hough and J.M. Picken, "Biochem. J.", 1965, 94, 75) was dissolved in a mixture of water (50 ml) and pyridine (5 ml) and heated at 135° for 3 h in an autoclave. The reaction mixture was evaporated under reduced pressure to remove most of the pyridine and then passed through an ion-exchange column (H+ form). The acidic eluant was collected and concentrated to a brown syrup in vacuo and then dissolved in acetone (300 ml), 2,2-dimethoxypropane (10 ml) and sulphuric acid (0.2 ml) were added and the solution left standing overnight. The solvent was removed in vacuo and the residue chromatographed on silica gel using ethyl acetate-hexane (1:1) to give the crude crystalline product (0.76 g). Recrystallization from ethyl of acetate-hexane gave colourless crystals 2,3-isopropylidene-L(―)-ribonic acid-1,4-lactone (0.38 g), m.p. 137-9°,
    Figure imgb0073
    (c = 1.5, CHCl3). 1HNMR spectrum: 8 (CDCI3) 4.75, 2H, m; 4.55, 1H, m; 3.85, 2H, m; 2.55, 1H, t, J 6 Hz; 1.45, 3H, s; 1.37, 3H, s. Mass specrum: M+ -15 173 (90%), 129 (11), 85 (19), 59 (34), 43 (100).
  • Example 25:
  • Potassium L-arabonate (prepared by the method of P. Andrews, L. Hough and J.M. Picken, "Biochem. J.", 1965, 94, 75) was dissolved in water and passed through a Biorad® AG50 x 8 200-400 mesh in ion-exchange column (H form). The acidic eluant was collected and concentrated to a colourless syrup of L-arabonic acid (14.75 g). The syrup was dissolved in acetone (300 ml) and sulphuric acid (0.5 ml) and cupric sulphate (31 g) was added and the mixture stirred at room temperature for 24 h. Thin-layer chromatography on silica gel (ethyl acetate solvent) indicated partial conversion to product. After neutralizing the acid with concentrated aqueous ammonia the mixture was filtered and the filtrate was concentrated in vacuo. The residue was chromatographed on silica gel using ethyl acetate- hexane (1 :1 ) to give the crude crystalline product (4.87 g). Recrystallization from ethyl acetate- hexane gave colourless crystals of 3,4-isopropylidene-L-arabino-1,5-lactone (3.71 g); m.p. 96-7°,
    Figure imgb0074
    (c = 3, CHCI3). 1HNMR spectrum: 4.39, 5H, m; 3.60, 1 H, d, J 3 Hz; 1.50, 3H, s; 1.37, 3H, s. Mass spectrum: measured M+ -15 173.0442, C7H9O5 requires 173.0450.

Claims (29)

1. A process for the resolution of racemic carboxylic acids into their optically active enantiomers involving esterification with an optically active compound, characterized in that an optically active enantiomer of 2,3-isopropylidene-ribonic acid-1,4-factone; 1,2-isopropylidene- glucofuranurono-3,6-lactone; 2-hydroxy-3,3-dimethyl-1,4-butyrolactone or 3,4-isopropylidene-arabino-1,5-lactone is used as the resolving agent.
2. A process as claimed in Claim 1, characterized in that the racemic carboxylic acid is esterified with an optically active enantiomer of 2,3-isopropylidene-ribonic acid-1,4-lactone; 1,2-isopropylidene-glucofuranurono-3,6- lactone; 2-hydroxy-3,3-dimethyl-1,4-butyrolactone or 3,4-isopropylidene-arabino-1,5-lactone and the resulting diastereoisomeric esters are separated.
3. A process as claimed in Claim 2, wherein the diastereoisomeric esters are separated by crystallization or chromatography.
4. A process as claimed in Claim 3, wherein the chromatography method used is high-performance liquid chromatography.
5. A process as claimed in any one of Claims 2 to 4, characterized in that a separated diastereoisomeric ester is hydrolysed to its corresponding enantiomeric carboxylic acid.
6. A process as claimed in any one of Claims 1 to 5, wherein the resolving agent used is D (―)-2-hydroxy-3,3-dimethyl-1,4-butyrolactone.
7. A process as claimed in any one of Claims 1 to 5, wherein the resolving agent used is L(+)-2-hydroxy-3,3-dimethyl-1,4-butyrolactone.
8. A process as claimed in any one of Claims 1 to 5, wherein the resolving agent used is 1,2―isopropylidene-(+)-α-D-glucofuranurono-3,6-lactone.
9. A process as claimed in any one of Claims 1 to 5, wherein the resolving agent used is 1;2-isopropylidene-(―)-α-L-glucofuranurono-3,6-lactone.
10. A process as claimed in any one of Claims 1 to 5, wherein the resolving agent used is 2,3-isopropylidene-D(+)-ribonic acid-1,4-lactone.
11. A process as claimed in any one of Claims 1 to 5, wherein the resolving agent used is 2,3-isopropylidene-L(-)-ribonic acid-1,4-tactone.
. 12. A process as claimed in any one of Claims 1 to 5, wherein the resolving agent used is 3,4-isopropylidene-L-arabino-1,5-lactone.
13. A process as claimed in any one of Claims 1 to 5, wherein the resolving agent used is 3,4-isopropylidene-D-arabino-1,5-lactone.
14. A process as claimed in any one of the preceding claims, wherein the carboxylic acid is an amino acid, a mercapto carboxylic acid, a cycloalkyl acid, an aralkyl acid or a heterocyclic acid wherein the hetero atom is nitrogen, oxygen or sulfur.
15. A process as claimed in any one of Claims 1 to 14, wherein the carboxylic acid has the formula:
Figure imgb0075
in which R1 represents hydrogen or a C1-C9 alkoxy group, a C1-C9 alkylthio group, fluoro, chloro, bromo, a C1-C9 alkyl group, a nitro or amino group, R2 represents hydrogen or a C1-C9 alkyl group or R1 and R2 together represents a methylenedioxy group, and R4 and R5 are the same or different and represent fluoro, bromo, chloro or a C1-C9 alkyl group.
16. A process as claimed in any one of Claims 1 to 14, wherein the carboxylic acid is:
Cis-3-(2,2-dichlorovinyl)-2,2-dimethyl-cyclopropane carboxylic acid;
Cis/trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid;
Cis-3-(2,2-dibromovinyl)-2,2-dimethyl-cyclopropane carboxylic acid;
3-(1,2-Dibromo-2,2-dichloroethyl)-2,2-dimethyl-cyclopropane carboxylic acid;
2,2-Dimethyl-3-(2,2,2-trichloroethyl)-cyclopropane carboxylic acid;
2,2-Dimethyl-4,5-benzospiro- [2,4] -hepta-4,6-diene-1-carboxylic acid;
Cis-3-(Z-2-chloro,3,3,3-trifluoroprop-1 -en- yl)-2,2-dimethyl-cyclopropane carboxylic acid;
2-(2-Chloro-a,a,a-trifluoro-p-toluidino)-3-methyl lactic acid;
2-(4-Chlorophenyl)-3-methyl lactic acid;
2-(4-Chlorophenoxy)-3-methyl butanoic acid;
2-(4-Difluoromethoxyphenyl)-3-methyl lactic acid;
1-(4-Ethoxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid;
1-(4-Bromophenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid;
1-(4-Ethoxyphenyl)-2,2-dichlorocyclopro- pane carboxylic acid;
1-(4-Chlorophenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid;
1-(3,4-Methylenedioxyphenyl)-2,2,3,3-tetrafluorocyclobutane carboxylic acid;
2,2-Dimethyl-3-(2,2-dichlorovinyl)-cyclopropane carboxylic acid; or
1,4,5,6,7,7-Hexachloro-8,9,10-trinorborn-5- ene-2-carboxylic acid.
17. A process as claimed in any one of Claims 1 to 13, wherein the carboxylic acid is a dibenzofuran derivative, dibenzothiophen derivative or a carbazole.
18. A process as claimed in Claim 17, wherein the carboxylic acid is 6-chloro-a-methyl- carbazole-2-acetic acid.
19. A process as claimed in Claim 17, wherein the carboxylic acid is 8-chloro-a-methyl-3-dibenzofuran acetic acid.
20. Lactone esters of an optically active enantiomer of 2,3-isopropylidene-ribonic acid-1,4- lactone; 1,2-isopropylidene-glucofuranurono-3,6-lactone; 2-hydroxy-3,3-dimethyl-1,4-butyrolactone or 3,4-isopropylidene-arabino-1,5- lactone and an optically active carboxylic acid, said acid being either in racemic form or as a single optically active enantiomer thereof.
21. A lactone ester as claimed in Claim 20, wherein the lactone ester is an ester of 2,3-isopropylidene-D(+)-ribonic acid-1,4-tactone.
22. A lactone ester as claimed in Claim 20, wherein the lactone ester is an ester of 2,3-isopropylidene-L(-)-ribonic acid-1,4-iactone.
23. A lactone ester as claimed in Claim 20, wherein the lactone ester is an ester of 1,2-isopropylidene-(+)-α-D-glucofuranurono-3,6-lactone.
24. A lactone ester as claimed in Claim 20, wherein the lactone ester is an ester of 1,2-isopropylidene-(-)-a-L-glucofuranurono-3,6-lactone.
25. A lactone ester as claimed in Claim 20, wherein the lactone ester is an ester of D (―)-2-hydroxy-3,3-dimethyl-1,4-butyrolactone.
26. A lactone ester as claimed in Claim 20, wherein the lactone ester is an ester of L(+)-2-hydroxy-3,3-dimethyl-1,4-butyrolactone.
27. A lactone ester as claimed in Claim 20, wherein the lactone ester is an ester of 3,4-isopropylidene-L-arabino-1,5-lactone.
28. A lactone ester as claimed in Claim 20, wherein the lactone ester is an ester of 3,4-isopropylidene-D-arabino-1,5-lactone.
29. A lactone ester as claimed in any one of Claims 20 to 28, wherein the carboxylic acid is one as set forth in any one of Claims 15 to 17.
EP82101654A 1981-03-12 1982-03-04 Process for the resolution of racemates and lactone esters used in said process Expired EP0060445B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8107737 1981-03-12
GB8107737 1981-03-12
GB8203596 1982-02-08
GB8203596 1982-02-08

Publications (2)

Publication Number Publication Date
EP0060445A1 EP0060445A1 (en) 1982-09-22
EP0060445B1 true EP0060445B1 (en) 1984-08-01

Family

ID=26278733

Family Applications (1)

Application Number Title Priority Date Filing Date
EP82101654A Expired EP0060445B1 (en) 1981-03-12 1982-03-04 Process for the resolution of racemates and lactone esters used in said process

Country Status (4)

Country Link
US (2) US4501908A (en)
EP (1) EP0060445B1 (en)
AU (1) AU8108782A (en)
DE (1) DE3260485D1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US4980065A (en) * 1989-10-18 1990-12-25 Lehigh University Separation of mixtures by aqueous two-phase systems
US5078886A (en) * 1989-10-18 1992-01-07 Lehigh University Separation of mixtures by two-phase systems
WO2006013929A1 (en) * 2004-08-05 2006-02-09 Godo Shusei Co., Ltd. Composition for accelerating calcium absorption
EP2364083A4 (en) * 2008-12-10 2012-10-31 Metaproteomics Llc A method for the purification of substituted cyclopent-2-en-1-one congeners and substituted 1,3-cyclopentadione congeners from a complex mixture using countercurrent separation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3185710A (en) * 1961-09-06 1965-05-25 Nopco Chem Co Resolution of pantolactone and phenylethylamine
AR205331A1 (en) * 1972-07-24 1976-04-30 Hoffmann La Roche PROCEDURE FOR THE PREPARATION OF CARBAZOLES
US4022805A (en) * 1974-03-07 1977-05-10 Hoffmann-La Roche Inc. 8-Halo-dibenzofuran-3-acetic acids and certain esters thereof
DE2650232A1 (en) * 1976-11-02 1978-05-11 Basf Ag Process for the preparation of amines
DE2800922A1 (en) * 1978-01-10 1979-07-19 Bayer Ag PROCESS FOR THE SEPARATION OF STEREOISOMER VINYLCYCLOPROPANIC CARBONIC ACIDS
US4201874A (en) * 1978-03-13 1980-05-06 Zoecon Corporation 3-Isopropenyl-6-heptenoic acid

Also Published As

Publication number Publication date
AU8108782A (en) 1982-09-16
US4855446A (en) 1989-08-08
US4501908A (en) 1985-02-26
DE3260485D1 (en) 1984-09-06
EP0060445A1 (en) 1982-09-22

Similar Documents

Publication Publication Date Title
US4761420A (en) Antihypertensive dihydropyridine derivatives
EP0060445B1 (en) Process for the resolution of racemates and lactone esters used in said process
US4622419A (en) Process for the optical resolution of racemic mixtures of α-naphthyl-propionic acids
EP0214426B1 (en) Intermediates in the synthesis of carboxylic acids
US4345090A (en) Process for preparing menthyl esters of enantiomers of chiral 3-(2,2-dichloro- and -dibromo-vinyl)-2,2-dimethylcyclopropanecarboxylic acids
RU2015953C1 (en) Process for splitting 2,2-dimethylcyclopropanecarboxylic acid racemate
NO761142L (en)
US4304930A (en) Process for the preparation of 2-(3-phenoxy-phenyl)-propionic acid
US4508919A (en) Process for the preparation of optically active cyclopropane carboxylic acids
US4414391A (en) A process for preparing 2-pyridinyloxyphenoxy-lower-alkanoates
US4599444A (en) Process for the separation of isomeric cyclopropane-carboxylic acids
US4983758A (en) Process for producing an optically active α-isopropyl-p-chlorophenylacetic acid
JP3766463B2 (en) Process for producing enantiomers of 2- (2-fluoro-4-biphenyl) propionic acid
WO1990008126A1 (en) Resolution process
JPH0227994B2 (en)
US4304942A (en) Producing substituted 2-cyclopentenones
DE3906460C1 (en)
JPH11322665A (en) Purification of optically active alpha-trifluoromethyl lactic acid
SU343436A1 (en) METHOD FOR OBTAINING ARARROXY DERIVATIVES
SU528865A3 (en) Method for preparing β-phenyl fatty acid derivatives or their salts
SU786888A3 (en) Method of preparing polysubstituted 4-alkylaminobenzoic acid esters
HU194531B (en) Process for producing esters of 2,2-dimethyl-cyclopropane-1,3-dicarboxylic acids
JPH0662505B2 (en) α-Isopropyl-p-chlorophenylacetic acid esters and method for producing the same
HU197866B (en) Process for resolving cys-2,2-dimethyl-3-/2,2-disubsti-tuted-vinyl/-cyclopropane-carboxylic acid
JPH0597835A (en) Production of @3754/24)r,z)-5-dodecen-4-olide

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH DE FR GB IT LI

Designated state(s): CH DE FR GB IT

17P Request for examination filed

Effective date: 19820304

ITF It: translation for a ep patent filed
GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): CH DE FR GB IT LI

Designated state(s): CH DE FR GB IT LI

REF Corresponds to:

Ref document number: 3260485

Country of ref document: DE

Date of ref document: 19840906

ET Fr: translation filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Effective date: 19850331

Ref country code: CH

Effective date: 19850331

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19851129

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Effective date: 19851203

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

GBPC Gb: european patent ceased through non-payment of renewal fee
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Effective date: 19881121